Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Peacock

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Journal of Clinical Medicine|October 17, 2020
Acceptability and Usefulness of a Dyadic, Tailored, Web-Based, Psychosocial and Physical Activity Self-Management Program (TEMPO): A Qualitative StudySylvie D Lambert, Lindsay Rosamond Duncan, Janet Ellis, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (<i>TEMPO</i>) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot TrialSylvie D Lambert, Lindsay R Duncan, S Nicole Culos-Reed, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in CanadaQi Guan, Suriya J Aktar, Reka E Pataky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 8, 2022
"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare CostsDouglas C Cheung, Karen E Bremner, Teresa C O Tsui, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Plos One|September 8, 2023
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysisSeraphine Zeitouny, Douglas C Cheung, Karen E Bremner, et al.
CMAJ Open|September 20, 2022
Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort studyTeresa C O Tsui, Seraphine Zeitouny, Karen E Bremner, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Journal of Clinical Medicine|October 17, 2020
Acceptability and Usefulness of a Dyadic, Tailored, Web-Based, Psychosocial and Physical Activity Self-Management Program (TEMPO): A Qualitative StudySylvie D Lambert, Lindsay Rosamond Duncan, Janet Ellis, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Feasibility, Acceptability, and Clinical Significance of a Dyadic, Web-Based, Psychosocial and Physical Activity Self-Management Program (<i>TEMPO</i>) Tailored to the Needs of Men with Prostate Cancer and Their Caregivers: A Multi-Center Randomized Pilot TrialSylvie D Lambert, Lindsay R Duncan, S Nicole Culos-Reed, et al.
Pharmacoeconomics|December 23, 2017
Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30Madeleine T King, Rosalie Viney, A Simon Pickard, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
Real-World Safety of Niraparib for Maintenance Treatment of Ovarian Cancer in CanadaQi Guan, Suriya J Aktar, Reka E Pataky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 8, 2022
"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare CostsDouglas C Cheung, Karen E Bremner, Teresa C O Tsui, et al.
BMJ Open|January 20, 2019
Health-related quality of life and anxiety in the PAN-CAN lung cancer screening cohortNiloofar Taghizadeh, Alain Tremblay, Sonya Cressman, et al.
Cancer|December 21, 2019
Value assessment of oncology drugs using a weighted criterion-based approachDoreen A Ezeife, Francois Dionne, Aline Fusco Fares, et al.
JAMA Network Open|August 2, 2022
Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, CanadaSteven Habbous, Xiaochen Tai, Jaclyn M Beca, et al.
Plos One|September 8, 2023
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysisSeraphine Zeitouny, Douglas C Cheung, Karen E Bremner, et al.
CMAJ Open|September 20, 2022
Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort studyTeresa C O Tsui, Seraphine Zeitouny, Karen E Bremner, et al.
Pageof 14